and 31 were assigned to 80 mg of atorvastatin daily plus placebo once every 2 weeks (Fig. S1 in the Supplementary Appendix). The baseline characteristics of the patients are shown in Table 1.

attained both the LDL-cholesterol and the blood pressure goals compared with those receiving either amlodipine or atorvastatin alone. Table 1. AVALON: Percentage of Patients at NCEP ATP III LDL ...

Atorvastatin is a generic prescription drug that’s used to lower cholesterol and lower risk of stroke and serious heart problems. Atorvastatin comes as an oral tablet. Atorvastatin is used along ...

Table 2 Rates of Primary and Secondary End Points. Death from all causes was similar in the two groups (48 percent in the atorvastatin group, as compared with 50 percent in the placebo group ...

Objective: Patient switching of prescription drug brands within a therapeutic class has become more prevalent with tiered drug plan formularies. Although switching from more expensive brand name ...

Here’s a table of drugs that can interact with atorvastatin. Keep in mind that this table doesn’t include all drugs that may interact with atorvastatin. Some of these interactions are ...

A post-hoc analysis showed atorvastatin was associated with a 22% reduction in the risk of ischemic stroke, but an increased risk of hemorrhagic stroke (Table 3). Prof. Amarenco stressed that ...

Rosuvastatin at both doses, 10 mg and 20 mg, significantly reduced the non-HDL cholesterol and TG levels of patients compared with atorvastatin (Table).

After 12 weeks of treatment, the mean scores for GEQ had improved significantly for men receiving atorvastatin compared with placebo (P=0.001) (Table 4). The percentage of subjects who responded ...

Atorvastatin market presents a detailed overview of the Atorvastatin Industry 2017 along with the key factors that are condemnatory in forming a holistic outline of the market, available at ...